Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05412121 · ClinicalTrials.gov registry record · NA

Acupressure in Rheumatoid Arthritis

A NA study of Rheumatoid Arthritis, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT05412121 is a NA study of Rheumatoid Arthritis that has completed, run by University of Michigan. The registered enrollment target is 14 participants, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05412121, a NA study of Rheumatoid Arthritis, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot trial is to better understand if acupressure is feasible and tolerable to people with rheumatoid arthritis.

Conditions Studied

Interventions

  • DEVICE Acupressure

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2022-09-15
Est. Completion 2023-07-20
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05412121

The ClinicalTrials.gov registry entry for NCT05412121 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Acupressure is the first listed.

NCT05412121 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05412121 about?

NCT05412121 is a clinical study titled "Acupressure in Rheumatoid Arthritis". The goal of this pilot trial is to better understand if acupressure is feasible and tolerable to people with rheumatoid arthritis.

What is the current status of trial NCT05412121?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-09-15. Estimated completion is 2023-07-20.

What conditions does trial NCT05412121 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT05412121?

The interventions under investigation include: Acupressure (DEVICE).

Who is sponsoring clinical trial NCT05412121?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05412121 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.